Morgan Stanley Nkarta, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Nkarta, Inc. stock. As of the latest transaction made, Morgan Stanley holds 323,625 shares of NKTX stock, worth $689,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares

323,625

Previous 467,481 30.77%

Holding current value

$689,321

Previous $860,000 37.56%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$1.51 - $2.22 $217,222 - $319,360	-143,856 Reduced 30.77%	323,625 $537,000
Q1 2025 May 15, 2025	SELL	$1.37 - $2.53 $1.76 Million - $3.26 Million	-1,286,863 Reduced 73.35%	467,481 $860,000
Q4 2024 Feb 14, 2025	BUY	$2.17 - $4.34 $2.99 Million - $5.99 Million	1,379,948 Added 368.58%	1,754,344 $4.37 Million
Q3 2024 May 14, 2025	BUY	$4.52 - $8.0 $327,686 - $579,976	72,497 Added 24.01%	374,396 $1.69 Million
Q3 2024 Nov 14, 2024	BUY	$4.52 - $8.0 $327,686 - $579,976	72,497 Added 24.01%	374,396 $1.69 Million
Q2 2024 May 14, 2025	SELL	$5.27 - $10.82 $7.65 Million - $15.7 Million	-1,452,445 Reduced 82.79%	301,899 $1.78 Million
Q2 2024 Oct 17, 2024	BUY	$5.27 - $10.82 $655,082 - $1.34 Million	124,304 Added 69.99%	301,899 $1.78 Million
Q2 2024 Aug 14, 2024	BUY	$5.27 - $10.82 $655,082 - $1.34 Million	124,304 Added 69.99%	301,899 $1.78 Million
Q1 2024 Oct 17, 2024	SELL	$5.59 - $15.71 $694,859 - $1.95 Million	-124,304 Reduced 41.17%	177,595 $1.92 Million
Q1 2024 Aug 16, 2024	SELL	$5.59 - $15.71 $209,166 - $587,836	-37,418 Reduced 17.4%	177,595 $1.92 Million
Q1 2024 May 15, 2024	SELL	$5.59 - $15.71 $209,166 - $587,836	-37,418 Reduced 17.4%	177,595 $1.92 Million
Q4 2023 Aug 16, 2024	SELL	$1.31 - $6.6 $113,820 - $573,447	-86,886 Reduced 28.78%	215,013 $1.42 Million
Q4 2023 Feb 13, 2024	SELL	$1.31 - $6.6 $6,420 - $32,346	-4,901 Reduced 2.23%	215,013 $1.42 Million
Q3 2023 Nov 15, 2023	SELL	$1.39 - $2.29 $15,003 - $24,718	-10,794 Reduced 4.68%	219,914 $305,000
Q2 2023 Aug 14, 2023	BUY	$2.19 - $5.17 $129,569 - $305,877	59,164 Added 34.49%	230,708 $505,000
Q1 2023 May 15, 2023	BUY	$3.37 - $6.3 $218,136 - $407,792	64,729 Added 60.6%	171,544 $608,000
Q4 2022 Feb 14, 2023	SELL	$5.14 - $14.35 $217,098 - $606,100	-42,237 Reduced 28.34%	106,815 $639,000
Q3 2022 Nov 14, 2022	SELL	$12.27 - $18.39 $3.15 Million - $4.71 Million	-256,359 Reduced 63.23%	149,052 $1.96 Million
Q2 2022 Oct 27, 2022	SELL	$7.77 - $19.44 $1.46 Million - $3.65 Million	-187,681 Reduced 31.64%	405,411 $5 Million
Q2 2022 Aug 15, 2022	SELL	$7.77 - $19.44 $1.46 Million - $3.65 Million	-187,681 Reduced 31.64%	405,411 $5 Million
Q1 2022 Oct 27, 2022	BUY	$8.66 - $14.99 $1.63 Million - $2.81 Million	187,681 Added 46.29%	593,092 $6.75 Million
Q1 2022 May 13, 2022	SELL	$8.66 - $14.99 $1.56 Million - $2.71 Million	-180,576 Reduced 23.34%	593,092 $6.75 Million
Q4 2021 Feb 14, 2022	BUY	$12.79 - $26.88 $8.34 Million - $17.5 Million	652,459 Added 538.29%	773,668 $11.9 Million
Q3 2021 Nov 15, 2021	BUY	$26.67 - $38.76 $3.23 Million - $4.7 Million	121,209 New	121,209 $3.37 Million

Others Institutions Holding NKTX

# of Institutions

112

Shares Held

59.1M

Call Options Held

Put Options Held

67.1K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $104M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account